<article id="neutropenia" class="slide" data-ag-slide-name="Neutropenia">
    <div class="basic">
       <div id="flow_holder">
          <div class="flow_top" id="neutropenia_main"><span></span><h1 data-ag-editable="Neutropenia Main Title">Neutropenia</h1></div>
          <div id="flow_left">
             <span></span>
             <div class="flow_link_holder" id="febrile_neutropenia_btn"><span></span><p data-ag-editable="Neutropenia Button 1">Febrile Neutropenia (FN)</p></div>
             <span></span>
             <div class="flow_link_holder" id="hospitalization_btn"><span></span><p data-ag-editable="Neutropenia Button 2">Complicated life threatening infection and prolonged hospitalisation<sup>1,4</sup></p></div>
             <span></span>
             <div class="flow_link_holder" id="early_mortality"><span></span><p data-ag-editable="Neutropenia Button 3">Early mortality due to infections and sepsis<sup>1,4,5</sup></p></div>
             <span class="flow_long_arrow"></span>
          </div>
          <div id="flow_right">
             <span></span>
             <div class="flow_link_holder" id="dose_delay"><span></span><p data-ag-editable="Neutropenia Button 4">Chemotherapy dose delays<br /> and dose reductions<sup>1-3</sup></p></div>
             <span></span>
             <div class="flow_link_holder" id="decreased_reductions"><span></span><p data-ag-editable="Neutropenia Button 5">Decreased relative dose intensity (RDI)<sup>1-3</sup></p></div>
             <span></span>
             <div class="flow_link_holder" id="less_effective"><span></span><p data-ag-editable="Neutropenia Button 6">Less effective chemotherapy<sup>1-3</sup></p></div>
             <span class="flow_long_arrow"></span>
          </div>
          <div class="flow_bottom" id="reduced_survival">
             <span></span><p data-ag-editable="Neutropenia Button 7" id="reduced_survival_button">Reduced survival<sup>1-5</sup></p>
          </div>
       </div>
    </div>
    <!-- Reference Information Starts -->
    <div class="lightbox_data" id="neutropenia_refs">
       <div class="main_content_style">
          <p><strong data-ag-editable="Neutropenia References Title">References:</strong></p>
          <div data-ag-editable="Neutropenia References List">
             <ol>
                <li>Aapro M <em>et al</em>. 2010 update of EORTC guidelines for the use of granulocytecolony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 2011; 47(1):8-32</li>
                <li>Bosly A <em>et al</em>. Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Hematol 2008; 87(4):277-283</li>
                <li>Chirivella L <em>et al</em>. Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients. Breast Cancer Res Treat 2009; 114(3):479-484</li>
                <li>Kuderer NM <em>et al</em>. Mortality, Morbidity, and Cost Associated with Febrile Neutropenia in Adult Cancer Patients. Cancer 2006; 106(10):2258-2266</li>
                <li>Lyman G <em>et al</em>. Risk of Mortality in Patients With Cancer Who Experience Febrile Neutropenia. Cancer 2010; 116(23):5555-5563</li>
             </ol>
          </div>
       </div>
    </div>
    <!-- Reference Information Ends -->
</article>